You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Surgically Eligible Basal Cell Carcinomas

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in United States (Patient-Specific Protocol, Weight-based Protocol, Morphine)

Terminated
  • Sickle Cell Disease
  • Patient-Specific Protocol
  • +3 more
  • Baltimore, Maryland
  • +5 more
May 24, 2022

Improvement of Fatigue Symptoms in Iron Deficiency Anemia With

Not yet recruiting
  • Anemia
  • +3 more
  • Fatigue
  • (no location specified)
May 26, 2022

Type 1 Diabetes Trial in New York (Evolocumab Cartridge, Atorvastatin Calcium Tablets, Ezetimibe Tablets)

Recruiting
  • Type 1 Diabetes
  • Evolocumab Cartridge
  • +6 more
  • New York, New York
  • +2 more
Nov 29, 2022

Split Thickness Skin Graft, Wound Healing Trial in Nantes (biological dressing, Paraffin gauze dressing)

Recruiting
  • Split Thickness Skin Graft
  • Wound Healing
  • biological dressing
  • Paraffin gauze dressing
  • Nantes, France
  • +1 more
Apr 4, 2022

Oropharyngeal Tumors Trial in Scottsdale, Saint Louis (Intensity-modulated radiation therapy (IMRT), Cisplatin)

Terminated
Has Results
  • Oropharyngeal Neoplasms
  • Intensity-modulated radiation therapy (IMRT)
  • Cisplatin
  • Scottsdale, Arizona
  • +1 more
Nov 10, 2020

Clubfoot Trial (Foot abduction bracing for clubfoot with novel dynamic bar, Foot abduction bracing for clubfoot with standard

Recruiting
  • Clubfoot
  • Foot abduction bracing for clubfoot with novel dynamic bar
  • Foot abduction bracing for clubfoot with standard straight bar
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Oct 21, 2022

Glaucoma Trial (Exercise, Bike exercise and muscle strength exercise.)

Not yet recruiting
  • Glaucoma
  • Exercise, Bike exercise and muscle strength exercise.
  • (no location specified)
Jan 27, 2023

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Endometrial Carcinoma Trial (Lerociclib, Letrozole 2.5mg, Placebo)

Not yet recruiting
  • Endometrial Carcinoma
  • (no location specified)
Jan 26, 2023

Chronic Kidney Diseases Trial in Wuhan (UC-MSC, Saline solution)

Recruiting
  • Chronic Kidney Diseases
  • UC-MSC
  • Saline solution
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Aug 21, 2022

NSCLC, Head and Neck Squamous Cell Carcinoma Trial in Israel, Japan, United States (ABBV-514, Pembrolizumab, Budigalimab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Fullerton, California
  • +13 more
Jul 11, 2022

Lung Cancer, NSCLC Trial in China, Thailand (Nivolumab)

Completed
  • Lung Cancer
  • Non-Small Cell Lung Cancer
  • Nivolumab
  • Beijing, Beijing, China
  • +29 more
Sep 24, 2021

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) Trial in China (MRG001)

Recruiting
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
  • Beijing, Beijing, China
  • +11 more
Feb 21, 2022

Head and Neck Tumor Trial in Milwaukee (50 Gy Radiation Therapy, 55 Gy Radiation Therapy, 60 Gy Radiation Therapy)

Recruiting
  • Head and Neck Neoplasm
  • 50 Gy Radiation Therapy
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert & Medical College of Wisconsin
Apr 21, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

B Cell Lymphoma Trial in Tel-Aviv (Nivolumab Injection [Opdivo])

Recruiting
  • B Cell Lymphoma
  • Nivolumab Injection [Opdivo]
  • Tel-Aviv, Israel
    Tel-Aviv Sourasky Medicak center / BMT Unit
May 22, 2022

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

B-cell Non-Hodgkin Lymphoma (NHL) Trial in Worldwide (Odronextamab)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (NHL)
  • Chicago, Illinois
  • +122 more
Apr 1, 2022

Addiction, Alcohol Use Disorder Trial in Baltimore (Take Control, Semaglutide)

Recruiting
  • Addiction
  • Alcohol Use Disorder
  • Baltimore, Maryland
    National Institute on Drug Abuse
Sep 2, 2023

Ph+ ALL, Bone Marrow Transplant, Minimal Residual Disease Trial in Tianjin (the usage of Olverembatinib combined with Inotuzumab

Not yet recruiting
  • Ph+ ALL
  • +2 more
  • the usage of Olverembatinib combined with Inotuzumab Ozogamicin
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 30, 2022

Prostate Cancer Trial in Québec (Pembrolizumab)

Recruiting
  • Prostate Cancer
  • Québec, Canada
    CHU de Québec-Université Laval
Mar 8, 2022

NSCLC Trial in Tübingen, Münich, Heidelberg (Photons)

Recruiting
  • Non-small Cell Lung Cancer
  • Photons
  • Tübingen, Baden-Württemberg, Germany
  • +2 more
Aug 19, 2022

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant

Recruiting
  • Acute GVHD
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Jan 14, 2022

Stem Cells in NF1 Tumors of the Central Nervous System

Suspended
  • Neurofibromatosis Type 1
  • Tumors of the Central Nervous System
  • Collection of Stem Cells
  • Washington, District of Columbia
    Children's National Medical Center
Mar 8, 2022

NSCLC Trial in Qingdao (osimertinib oral and bevazizumab intravenously)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • osimertinib oral and bevazizumab intravenously
  • Qingdao, Shandong, China
    Qingdao Central Hospital, Qingdao Cancer Hospital
Nov 1, 2021